Update on Independent Service for Reusable Medical Devices
An update on current FDA and Congressional activity on independent service for reusable medical devices and the potential impact on your costs and level of service. Learn what you can do to get ready for potential changes that could affect your organization.
Related Resources
Letter/Comment
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
Issue Brief
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013.
Letter/Comment
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.
Toolkits/Methodology
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…
Request for Proposals (RFP)
Sample request for proposal for face-to-face spoken language and American Sign Language (ASL) interpreter services.
Advisory
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.